Trial Profile
A phase I trial of APG 101 for the prevention of acute graft-versus-host disease.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 12 Jan 2010
Price :
$35
*
At a glance
- Drugs Asunercept (Primary)
- Indications Graft-versus-host disease
- Focus Adverse reactions; Therapeutic Use
- Sponsors Apogenix
- 12 Jan 2010 New trial record